VICOR VP exercises options, sells 3,072 shares
VICOR CORP director and VP Global Sales & Marketing Philip D. Davies exercised stock options and sold shares in a pre-planned set of trades.
Rhea-AI Filing Summary
VICOR CORP director and VP Global Sales & Marketing Philip D. Davies exercised stock options and sold shares in a pre-planned set of trades. On June 1, 2026 he exercised 3,072 Non Qualified Stock Options at an exercise price of $30.98 per share, converting them into common stock.
That same day he sold 3,072 shares of common stock in a series of open-market transactions at prices generally in the low- to mid-$300s per share. According to the filing, these sales were executed under a Rule 10b5-1 trading plan adopted on November 21, 2025, indicating the trades were pre-scheduled as part of a trading program rather than discretionary same-day decisions.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 3,072 shares ($893K approx. pre-tax spread)
Exercise and Sale
13 txns
Insider
Davies Philip D
Role
VP Global Sales & Marketing
Sold
3,072 shs ($988K)
Approx. gross sale proceeds
$988K
Approx. exercise cost
$95K
Approx. pre-tax spread
$893K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non Qualified Stock Option | 3,072 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,072 | $30.98 | $95K |
| Sale | Common Stock | 300 | $314.1133 | $94K |
| Sale | Common Stock | 283 | $314.9376 | $89K |
| Sale | Common Stock | 200 | $316.265 | $63K |
| Sale | Common Stock | 17 | $317.8476 | $5K |
| Sale | Common Stock | 500 | $319.02 | $160K |
| Sale | Common Stock | 200 | $321.925 | $64K |
| Sale | Common Stock | 400 | $323.445 | $129K |
| Sale | Common Stock | 600 | $325.1817 | $195K |
| Sale | Common Stock | 100 | $326.93 | $33K |
| Sale | Common Stock | 372 | $328.4811 | $122K |
| Sale | Common Stock | 100 | $329.52 | $33K |
Holdings After Transaction:
Non Qualified Stock Option — 2,394 contracts (Direct);
Common Stock — 1,920 shares (Direct)
Footnotes (13)
- F1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.6500 to $314.6400.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.8000 to $315.2100.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.0000 to $316.5300.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.1700 to $318.1300.
- F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.5600 to $319.5200.
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.6900 to $322.1600.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.2100 to $323.5500.
- F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.6100 to $325.5300.
- F10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $326.9300 to $326.9300.
- F11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $328.1700 to $328.8800.
- F12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $329.5200 to $329.5200.
- F13. Options granted on 9/6/2019 and vest over five years.
Key Figures
Shares sold: 3,072 shares
Shares exercised: 3,072 shares
Option exercise price: $30.98 per share
+4 more
7 metrics
Shares sold
3,072 shares
Total common shares sold on June 1, 2026
Shares exercised
3,072 shares
Non Qualified Stock Options converted to common stock
Option exercise price
$30.98 per share
Strike price of options granted September 6, 2019
Sale price range (low)
$313.65 per share
Lowest weighted-average price range disclosed in footnotes
Sale price range (high)
$329.52 per share
Highest weighted-average price range disclosed in footnotes
Option expiration
September 6, 2029
Expiration date of Non Qualified Stock Options
Transactions under Rule 10b5-1 plan
1 plan referenced
Plan adopted November 21, 2025 governing June 1, 2026 sales
Key Terms
Rule 10b5-1 trading plan, Non Qualified Stock Option, weighted average price, derivative security, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Non Qualified Stock Option financial
"security_title":"Non Qualified Stock Option","transaction_date":"2026-06-01"
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
derivative security financial
"transaction_code_description":"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
open-market sale financial
"transaction_action":"open-market sale","transaction_code_description":"Sale in open market"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did VICR executive Philip D. Davies report?
Philip D. Davies reported exercising 3,072 Non Qualified Stock Options and selling 3,072 shares of VICOR CORP common stock. All transactions occurred on June 1, 2026 as open-market sales following the option exercise, according to the Form 4 filing.
What were the terms of the VICR options Philip D. Davies exercised?
Davies exercised 3,072 Non Qualified Stock Options with an exercise price of $30.98 per share. A footnote explains these options were granted on September 6, 2019 and vest over five years, with an expiration date of September 6, 2029.
Does Philip D. Davies still hold VICR stock after these transactions?
The Form 4 indicates he continues to hold VICOR CORP common stock directly after the transactions. The filing provides post-transaction share balances in the transaction table, but does not aggregate them into a single, clearly labeled total position line.
AI-generated analysis. How Rhea-AI works. Not financial advice.
